Bateman ED, Djukanovic R, Castro M, Canvin J, Germinaro M, Noble R, Garin M, Buhl R: Predicting Responders to Reslizumab After 16 Weeks of Treatment Using an Algorithm Derived From Clinical Studies of Patients with Severe Eosinophilic Asthma Am J Respir Crit Care Med : 2019.
Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M: Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps J Allergy Clin Immunol Pract : 2019.
Brusselle G., Germinaro M., Weiss S., Zangrill J: Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils Pulm Pharmacol Ther 43 : 39-45,2017.
Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M: Reslizumab for Inadequately Controlled Asthma with Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study CHEST 150 (4): 789-798,2016.
Germinaro, M., Reynolds, P., Knight, V., Alam, R: Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency Ann Allergy Asthma Immunol 115 (1): 82-83,2015.
Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK, Kokkinakis DM, Monga SP: Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma Neoplasia 8 (4): 279-289,2006.
Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A: beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation Cell and Tissue Research 323 (1): 71-79,2006.